Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

PIM1-Mediated CXCR4 Phosphorylation: A Potentially Class-Distinct Therapeutic Target of Next Generation Proteasome Inhibitors in Multiple Myeloma

Johannes M. Waldschmidt, MD, Dagmar Wider, Stefan J. Müller, Dipl.-Pharm., Anna Simon, Sarah Decker, PhD, Marie Follo, PhD, Justus Duyster, MD PhD, Ralph Wäsch, MD, Monika Engelhardt, MD PhD

Blood (2016) 128 (22): 2774.

https://doi.org/10.1182/blood.V128.22.2774.2774

Published: 2016

Journal Articles

Bone Marrow Interaction and Multiple Myeloma - Approximating Reality in Novel High-Throughput Multiple Myeloma Coculture Systems

Johannes Waldschmidt, MD, Dagmar Wider, Anna Simon, Andreas R. Thomsen, MD, Christine Aldrian, Marie Follo, PhD, Julia Schüler, Martin Kortum, MD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2014) 124 (21): 2243.

https://doi.org/10.1182/blood.V124.21.2243.2243

Published: 2014

Journal Articles

Investigation of the CXCL12-CXCR4/CXCR7 Axis in Multiple Myeloma (MM): Adhesion Molecules As Novel Targets of the Potent Proteasome Inhibitor Carfilzomib

Anna Simon, Dagmar Wider, Johannes Waldschmidt, MD, Marie Follo, PhD, Sarah Decker, PhD, Ralph Wäsch, MD, Monika Engelhardt, MD

Blood (2014) 124 (21): 927.

https://doi.org/10.1182/blood.V124.21.927.927

Published: 2014

Journal Articles

Targeting The Protective Microenvironment In Multiple Myeloma (MM): An Analysis Of The CXCL12/CXCR4-Axis and Its Inhibitors AMD3100 and Nox-A12 Combined With Antimyeloma Substances, Such As Pomalidomide and Carfilzomib

Anna Simon, Dagmar Wider, Marie Follo, PhD, Johannes Waldschmidt, Martina Kleber, Ralph Waesch, MD, Monika Engelhardt, MD

Blood (2013) 122 (21): 3851.

https://doi.org/10.1182/blood.V122.21.3851.3851

Published: 2013

Journal Articles

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome

Evelien J. Bodar, Jeroen C.H. van der Hilst, Waander van Heerde, Jos W. M. van der Meer, Joost P. H. Drenth, Anna Simon

Blood (2006) 109 (6): 2416–2418.

https://doi.org/10.1182/blood-2005-10-039578

Published: 2006

NARROW

PIM1-Mediated CXCR4 Phosphorylation: A Potentially Class-Distinct Therapeutic Target of Next Generation Proteasome Inhibitors in Multiple Myeloma

Bone Marrow Interaction and Multiple Myeloma - Approximating Reality in Novel High-Throughput Multiple Myeloma Coculture Systems

Investigation of the CXCL12-CXCR4/CXCR7 Axis in Multiple Myeloma (MM): Adhesion Molecules As Novel Targets of the Potent Proteasome Inhibitor Carfilzomib

Targeting The Protective Microenvironment In Multiple Myeloma (MM): An Analysis Of The CXCL12/CXCR4-Axis and Its Inhibitors AMD3100 and Nox-A12 Combined With Antimyeloma Substances, Such As Pomalidomide and Carfilzomib

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome

Email alerts

ASH Publications

American Society of Hematology

PIM1-Mediated CXCR4 Phosphorylation: A Potentially Class-Distinct Therapeutic Target of Next Generation Proteasome Inhibitors in Multiple Myeloma

Bone Marrow Interaction and Multiple Myeloma - Approximating Reality in Novel High-Throughput Multiple Myeloma Coculture Systems

Investigation of the CXCL12-CXCR4/CXCR7 Axis in Multiple Myeloma (MM): Adhesion Molecules As Novel Targets of the Potent Proteasome Inhibitor Carfilzomib

Targeting The Protective Microenvironment In Multiple Myeloma (MM): An Analysis Of The CXCL12/CXCR4-Axis and Its Inhibitors AMD3100 and Nox-A12 Combined With Antimyeloma Substances, Such As Pomalidomide and Carfilzomib

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only